Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News Thermo Fisher Scientific Nyse Tmo Has A Pretty Healthy Balance Sheet is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Thermo Fisher: A Hold For Stability, Not For Outperformance
Thermo Fisher Scientific is a high-quality, defensive investment with a strong moat but faces revenue growth headwinds and limited upside. Learn more about TMO stock here. Read More
Beyond The Numbers: 11 Analysts Discuss Thermo Fisher Scientific Stock
Insights from analysts' 12-month price targets are revealed, presenting an average target of $521.82, a high estimate of $590.00, and a low estimate of $450.00. Surpassing the previous average price ... Read More
Here’s What Dragged Thermo Fisher Scientific (TMO) in Q2
Renaissance Investment Management, an investment management company, released its Q2 2025 “Large Cap Growth Strategy” investor letter. A copy of the letter can be downloaded here. The stock market ... Read More
Here’s Why Thermo Fisher Scientific (TMO) Traded Lower in Q2
Loomis Sayles, an investment management company, released its “Growth Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the second quarter, the fund returned ... Read More
TD Cowen Sees Upside for Thermo Fisher (TMO) With Modest Q2 Growth

Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the best low volatility stocks to buy according to analysts. On July 16, TD Cowen maintained its Buy rating on Thermo Fisher Scientific Inc. Read More
13 Analysts Assess Thermo Fisher Scientific: What You Need To Know

During the last three months, 13 analysts shared their evaluations of Thermo Fisher Scientific (NYSE:TMO), revealing diverse outlooks from bullish to bearish. Summarizing their recent assessments, the ... Read More
Thermo Fisher Scientific: Recovery In Sight, Attractively Valued

Thermo Fisher has good growth prospects ahead. Core pharma, biotech, and bioproduction businesses are driving growth, with US manufacturing investments and the Solventum acquisition strengthening ... Read More
A Preview Of Thermo Fisher Scientific's Earnings

Thermo Fisher Scientific TMO is set to give its latest quarterly earnings report on Wednesday, 2025-07-23. Here's what investors need to know before the announcement. Analysts estimate that Thermo ... Read More
Thermo Fisher Scientific to Participate in J.P. Morgan CEO Call Series on September 5, 2025

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will ... Read More
Blow Us A Whistle

Comments (Whistles) Designed By Disqus